Calf Lung Surfactant- Respiratory Agent
Drug Name:
Calf Lung Surfactant- Respiratory Agent
List Of Brands:
Indication Type Description:
Indication:
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
Calf Lung surfactant intratracheal suspension 17-02-2011
containing phospholipids 35mg (containing
26mg phosphadylcholine of which 16mg is
disaturated phospatidylcholine) proteins
0.65mg (including 0.26mg of surfactant associated
proteins associated prootein B ) per ml
A. as a prophylaxis therapy for premature infants < 29 weeks of gestational
age at significant risk for respiratory distress syndrome (RDS)
B. For the treatment of infants < 72 hours of age with RDS ( confirmed by
clinical and radiologic findings ) and requiring endotracheal intubation
Dosages/ Overdosage Etc:
A. as a prophylaxis therapy for premature infants < 29 weeks of gestational
age at significant risk for respiratory distress syndrome (RDS)
B. For the treatment of infants < 72 hours of age with RDS ( confirmed by
clinical and radiologic findings ) and requiring endotracheal intubation